109 results
Page 3 of 6
424B5
bx5m154rtr9
4 Feb 21
Prospectus supplement for primary offering
4:01pm
424B5
icveil
2 Feb 21
Prospectus supplement for primary offering
4:29pm
8-K
EX-99.1
ye0zh 1z86raenbaj89
29 Dec 20
Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas
7:29am
8-K
EX-99.1
adr1iy
13 Nov 20
Moleculin Biotech, Inc. Reports Financial Results
7:29am
424B5
qff4j0y3m
12 Nov 20
Prospectus supplement for primary offering
4:31pm
S-8
EX-4.4
reyx8l
21 Aug 20
Registration of securities for employees
4:31pm
8-K
EX-1.1
66uv6z kz9
17 Jul 20
Entry into a Material Definitive Agreement
5:19pm
424B5
5qk8v2
17 Jul 20
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.1
ra7 xv9e44
19 Mar 20
Results of Operations and Financial Condition
4:16pm
424B5
dnn7ae6uf8xtnx8
6 Feb 20
Prospectus supplement for primary offering
5:08pm
8-K
EX-10.1
mhq5cw81w51nbg
6 Feb 20
Entry into a Material Definitive Agreement
9:06am
8-K
EX-1.1
jxziktmgb
6 Feb 20
Entry into a Material Definitive Agreement
9:06am